Health news and discussion on TalkFuse.
Experimental cancer drug could stop osteoporosis and help women stay slim after menopause
An experimental cancer drug called CADD522 has been found to strengthen bones and reduce fat gain in post-menopausal mice, offering a potential new approach to treating osteoporosis, a disease that affects around one in three women over 50. Unlike many existing treatments, which work by suppressing bone loss and can cause complications with long-term use, the drug appears to stimulate new bone growth without disrupting the body's natural bone renewal process, according to researchers at the University of East Anglia.
The study, published in the journal npj Drug Discovery, treated mice that had undergone surgery mimicking menopause with CADD522 for eight weeks, resulting in increased bone volume and better-preserved internal bone structure. Treated mice also weighed less and had less body fat despite eating the same amount as untreated mice, and the drug appeared to reverse some menopause-related changes in brain fatty acids. Safety tests in mice, rats and dogs showed the drug could be taken orally and was well tolerated, though researchers caution the work is still at an early, animal-only stage.
In short
- Cancer drug CADD522 strengthened bones and reduced fat in mice
- Could offer new osteoporosis treatment without typical side effects
- Still early-stage; only tested in animals so far
Explained simply
Osteoporosis is a condition where bones become weak and brittle, making fractures more likely. It becomes far more common after the menopause, when falling oestrogen levels speed up bone loss, and it is thought to affect around one in three women over 50. Current treatments mostly work by slowing down bone loss rather than building new bone, and can bring side effects if used for a long time.
CADD522 is a drug originally developed to treat cancer, but researchers at the University of East Anglia have been testing it for a completely different purpose: protecting bone strength and controlling weight gain after menopause. So far it has only been studied in animals, including mice bred to mimic menopause through surgery, as well as safety tests in rats and dogs. The findings were published in the journal npj Drug Discovery.
The research matters because it points to a possible new way of treating osteoporosis that works differently from existing drugs, potentially encouraging fresh bone growth rather than just preventing further loss, while also affecting body fat. It is still early-stage animal research, so it is not yet known whether the same effects would be seen, or be safe, in humans.
Health Medicine Research Science World